Brief: Equillium Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate & Clinical Development Updates
March 23 (Reuters) - Equillium Inc EQ.O :
* EQUILLIUM REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS AND PROVIDES CORPORATE & CLINICAL DEVELOPMENT UPDATES
* Q4 LOSS PER SHARE $0.36
* CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED
$80.7
MILLION AS OF DECEMBER 31, 2021
* BELIEVES THAT ITS CASH AND INVESTMENTS WILL BE SUFFICIENT
TO
FUND ITS CURRENTLY PLANNED OPERATIONS FOR AT LEAST NEXT 12
MONTHS
* Q4 EARNINGS PER SHARE VIEW $-0.34 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw431kcwa
Further company coverage: EQ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Equillium
See all newsBrief: Equillium Receives Australian Regulatory Clearance To Initiate First-In-Human Clinical Trial Of Eq504
Equillium Inc reports results for the quarter ended June 30 - Earnings Summary
Equillium Q2 post narrower net loss than expected; starts R&D initiatives
Equillium Inc expected to post a loss of 5 cents a share - Earnings Preview
Equillium Q1 net loss, profit miss analyst expectations